Načítá se...
7‐Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir
Dolutegravir (DTG), an important active pharmaceutical ingredient (API) used in combination therapy for the treatment of HIV, has been synthesized in continuous flow. By adapting the reported GlaxoSmithKline process chemistry batch route for Cabotegravir, DTG was produced in 4.5 h in sequential flow...
Uloženo v:
| Vydáno v: | Angew Chem Int Ed Engl |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6033037/ https://ncbi.nlm.nih.gov/pubmed/29756689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.201802256 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|